By Sarah Boseley as originally published in The Guardian
The multinational drug company Abbott is being targeted by health campaigners in a number of countries in a concerted campaign to try to break its monopoly on a valuable AIDS drug called Kaletra. …

Public Citizen in the USA is leading the charge, but campaigners in Brazil, India, Vietnam, Indonesia, Colombia, Thailand, the Netherlands and elsewhere are all taking action – mostly by challenging Abbott’s monopoly in their own legal systems. One company is being challenged, over one drug, but Public Citizen believes the orchestrated attack has greater significance —>Continue reading